Primer: Rigel Pharmaceuticals (RIGL US) - Oct 2025
Rigel Pharmaceuticals is a commercial-stage biotechnology company focused on hematologic disorders, cancer, and rare immune diseases. Its lead...
235 Views
Kissei Pharmaceutical (4547 JP): FY25 Looks Stable; Recent Licensing Deals Key To Near Term Growth
​Kissei Pharmaceutical sees 14% revenue growth in 9MFY25 driven by key drugs despite price pressures and generics, maintains FY25 guidance, with...
296 Views
No more insights